RDGLOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
VIVOS INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$0.05−0.00 (-2.51%)
Close on Oct 19, 2026
- Market cap
- $23.44M
- P/E (TTM)
- –
- Dividend yield
- –
Vivos statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Surgical & Medical Instruments & Apparatus companies for comparison
Valuation
| Measure | Vivos | Industry median |
|---|---|---|
| Market Cap | $23.61M | $230.55M |
| Enterprise Value | $21.27M | $202.97M |
| PS Ratio | 238.23 | 3.11 |
| PB Ratio | 8.57 | 3.14 |
| P/TBV Ratio | 8.57 | 4.57 |
Enterprise value
| Measure | Vivos | Industry median |
|---|---|---|
| EV / Sales | 214.66 | 2.92 |
Income (trailing twelve months)
| Measure | Vivos | Industry median |
|---|---|---|
| Revenue | $99.10K | $102.39M |
| Gross Profit | -$25.66K | $60.36M |
| Operating Income | -$2.83M | -$4.31M |
| Pretax Income | -$3.60M | -$2.26M |
| Net Income | -$3.60M | -$6.57M |
| EBITDA | -$2.83M | -$1.98M |
| EPS (Diluted) | $0.00 | -$0.07 |
Margins
| Measure | Vivos | Industry median |
|---|---|---|
| Gross Margin | -25.9% | 55.1% |
| Operating Margin | -2852.5% | -6.04% |
| Pretax Margin | -3633.6% | -4.11% |
| Profit Margin | -3633.6% | -10.5% |
| EBITDA Margin | -2852.5% | -2.67% |
Returns
| Measure | Vivos | Industry median |
|---|---|---|
| Return on Equity (ROE) | -132.5% | -19.2% |
| Return on Assets (ROA) | -127.3% | -13.3% |
| Return on Invested Capital (ROIC) | -1019.5% | -4.11% |
| Return on Capital Employed (ROCE) | -99.9% | -9.07% |
Growth
| Measure | Vivos | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 91.5% | 8.85% |
| Revenue Growth (3Y CAGR) | 23.3% | 7.08% |
| Revenue Growth (5Y CAGR) | 57.7% | 11.8% |
Balance sheet
| Measure | Vivos | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $2.34M | $37.33M |
| Net Cash (Debt) | $2.34M | $3.92M |
| Net Cash Per Share | $0.00 | $0.28 |
| Equity (Book Value) | $2.76M | $57.36M |
| Book Value Per Share | $0.01 | $2.81 |
| Tangible Book Value | $2.76M | $10.71M |
| Working Capital | $2.39M | $54.64M |
Financial position
| Measure | Vivos | Industry median |
|---|---|---|
| Current Ratio | 48.85 | 2.50 |
| Quick Ratio | 47.06 | 1.54 |
Cash flow (trailing twelve months)
| Measure | Vivos | Industry median |
|---|---|---|
| Operating Cash Flow | -$2.17M | -$653.46K |
Efficiency
| Measure | Vivos | Industry median |
|---|---|---|
| Asset Turnover | 0.04 | 0.59 |
| Inventory Turnover | 2.09 | 2.21 |
| Revenue Per Employee | $99.10K | $322.57K |
| Profits Per Employee | -$3.60M | -$51.88K |
| Employee Count | 1 | 185 |
Dividends and yields
| Measure | Vivos | Industry median |
|---|---|---|
| Earnings Yield | -15.3% | -6.91% |
Shares
| Measure | Vivos | Industry median |
|---|---|---|
| Shares Outstanding | 494,214,000 | 44,856,700 |
| Shares Change (YoY) | 6.55% | 3.35% |
| Shares Change (QoQ) | 2.36% | 0.27% |
| Float | 481,232,000 | 37,097,900 |
| Shares Held by Insiders | 2.63% | 10.6% |
Scores
| Measure | Vivos | Industry median |
|---|---|---|
| Altman Z-Score | 68.10 | 1.95 |
| Piotroski F-Score | 4 | 5 |
Calculated by StockData from Vivos's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.